Usefulness of Blood Parameters for Preliminary Diagnosis of Brucellosis.

blood cell count blood parameters brucellosis diagnosis

Journal

Journal of blood medicine
ISSN: 1179-2736
Titre abrégé: J Blood Med
Pays: New Zealand
ID NLM: 101550884

Informations de publication

Date de publication:
2020
Historique:
received: 13 01 2020
accepted: 17 03 2020
entrez: 14 4 2020
pubmed: 14 4 2020
medline: 14 4 2020
Statut: epublish

Résumé

Human brucellosis is a multisystem disease with a wide range of clinical signs which often leads to misdiagnosis and treatment delay. Early diagnosis of this disease can prevent the serious complications and mismanagements. This study aimed to evaluate the hematological parameters with predictive value for the diagnosis of brucellosis. In this prospective case-control study which was done during 2015-2017 in Imam Reza Hospital, Kermanshah Province, west Iran, 100 patients with a confirmed diagnosis of brucellosis (brucellosis group) and 100 healthy individuals (control group) were studied. The hematological parameters, including hemoglobin (Hb), red blood cell (RBC), white blood cell (WBC) count, lymphocyte count, neutrophil count, platelet count (PLTs), mean platelet volume (MPV), platelet distribution width (PDW), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) of both groups were recorded. The data were statistically compared between the brucellosis and the control groups. The mean age of patients and healthy groups was 44.04 ± 23.11 and 37.92 ± 24.80, respectively (P = 0.062). The WBC, CRP and neutrophil counts were significantly higher in the brucellosis group (P < 0.05). Based on the receiver operating characteristic (ROC) analysis, the sensitivity and specificity were 54% and 66% for the WBC, 45% and 71% for the neutrophil and 65% and 72% for the CRP, respectively. There was no statistically significant difference between the two groups in terms of Hb, RBC, WBC, lymphocyte and platelet count, MPV, PDW and ESR (P > 0.05). The results of this study indicate that WBC, CRP and neutrophil count can be used as valuable markers in the preliminary diagnosis of brucellosis. However, further researches are required to standardize these parameters for various forms of brucellosis.

Sections du résumé

BACKGROUND BACKGROUND
Human brucellosis is a multisystem disease with a wide range of clinical signs which often leads to misdiagnosis and treatment delay. Early diagnosis of this disease can prevent the serious complications and mismanagements. This study aimed to evaluate the hematological parameters with predictive value for the diagnosis of brucellosis.
METHODS METHODS
In this prospective case-control study which was done during 2015-2017 in Imam Reza Hospital, Kermanshah Province, west Iran, 100 patients with a confirmed diagnosis of brucellosis (brucellosis group) and 100 healthy individuals (control group) were studied. The hematological parameters, including hemoglobin (Hb), red blood cell (RBC), white blood cell (WBC) count, lymphocyte count, neutrophil count, platelet count (PLTs), mean platelet volume (MPV), platelet distribution width (PDW), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) of both groups were recorded. The data were statistically compared between the brucellosis and the control groups.
RESULTS RESULTS
The mean age of patients and healthy groups was 44.04 ± 23.11 and 37.92 ± 24.80, respectively (P = 0.062). The WBC, CRP and neutrophil counts were significantly higher in the brucellosis group (P < 0.05). Based on the receiver operating characteristic (ROC) analysis, the sensitivity and specificity were 54% and 66% for the WBC, 45% and 71% for the neutrophil and 65% and 72% for the CRP, respectively. There was no statistically significant difference between the two groups in terms of Hb, RBC, WBC, lymphocyte and platelet count, MPV, PDW and ESR (P > 0.05).
CONCLUSION CONCLUSIONS
The results of this study indicate that WBC, CRP and neutrophil count can be used as valuable markers in the preliminary diagnosis of brucellosis. However, further researches are required to standardize these parameters for various forms of brucellosis.

Identifiants

pubmed: 32280292
doi: 10.2147/JBM.S245513
pii: 245513
pmc: PMC7125307
doi:

Types de publication

Journal Article

Langues

eng

Pagination

107-113

Informations de copyright

© 2020 Akya et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Vet Ital. 2018 Jun 30;54(2):107-114
pubmed: 30019327
Int Braz J Urol. 2018 Jul-Aug;44(4):771-778
pubmed: 29697933
J Biomark. 2016;2016:2198745
pubmed: 27610265
Med Arch. 2018 Feb;72(1):17-21
pubmed: 29416212
Ital J Pediatr. 2016 Jan 11;42:3
pubmed: 26753565
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
Front Immunol. 2019 Aug 20;10:1759
pubmed: 31481953
Open Forum Infect Dis. 2015 Jul 03;2(3):ofv098
pubmed: 26258155
Microb Pathog. 2017 Aug;109:239-247
pubmed: 28602839
Cardiol Young. 2018 Jun;28(6):832-836
pubmed: 29656728
J Clin Pathol. 1983 Nov;36(11):1320
pubmed: 6630582
Rev Sci Tech. 2013 Apr;32(1):137-47
pubmed: 23837372
Iran Biomed J. ;21(6):349-59
pubmed: 28766326
BMJ. 2006 Apr 8;332(7545):838-41
pubmed: 16601046
Front Immunol. 2015 Jan 06;5:678
pubmed: 25610439
BMJ Open. 2019 Apr 8;9(4):e027748
pubmed: 30962240
Jundishapur J Microbiol. 2015 Feb 20;8(2):e20039
pubmed: 25825650
Biomed Res Int. 2016;2016:7508763
pubmed: 27419136
Turk J Pediatr. 2011 Jul-Aug;53(4):413-24
pubmed: 21980844
Afr Health Sci. 2018 Dec;18(4):988-994
pubmed: 30766564
Case Rep Med. 2012;2012:473784
pubmed: 23118764
Immunol Res. 2001;24(2):163-76
pubmed: 11594454
Korean J Intern Med. 2017 Nov;32(6):1075-1081
pubmed: 27951626
Afr Health Sci. 2014 Dec;14(4):797-801
pubmed: 25834485
Microbes Infect. 2009 May-Jun;11(6-7):689-97
pubmed: 19376263

Auteurs

Alisha Akya (A)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Arezoo Bozorgomid (A)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Kayghobad Ghadiri (K)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mahnaz Ahmadi (M)

Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Azam Elahi (A)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Hadi Mozafari (H)

Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Afshin Almasi (A)

Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Parvin Namadi (P)

Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Roya Chegenelorestani (R)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Classifications MeSH